|
1
|
Kent EE, Ambs A, Mitchell SA, Clauser SB,
Smith AW and Hays RD: Health-related quality of life in older adult
survivors of selected cancers: Data from the SEER-MHOS linkage.
Cancer. 121:758–765. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chow WH, Devesa SS, Warren JL and Fraumeni
JF Jr.: Rising incidence of renal cell cancer in the United States.
JAMA. 281:1628–1631. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Webster CR, Johnston A and Anwer MS:
Protein kinase Cδ protects against bile acid apoptosis by
suppressing pro-apoptotic JNK and BIM pathways in human and rat
hepatocytes. Am J Physiol Gastrointest Liver Physiol.
307:G1207–G1215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nishizuka Y: Intracellular signaling by
hydrolysis of phospholipids and activation of protein kinase C.
Science. 258:607–614. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aaltonen V and Peltonen J: Protein Kinase
C FamilyEncyclopedia of Cancer. Schwab M: Springer; Berlin: pp.
2469–2472. 2009
|
|
6
|
Fields AP and Murray NR: Protein kinase C
isozymes as therapeutic targets for treatment of human cancers. Adv
Enzyme Regul. 48:166–178. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang LL, Cao FF, Wang Y, Meng FL, Zhang
Y, Zhong DS and Zhou QH: The protein kinase C (PKC) inhibitors
combined with chemotherapy in the treatment of advanced non-small
cell lung cancer: Meta-analysis of randomized controlled trials.
Clin Transl Oncol. 17:371–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mandil R, Ashkenazi E, Blass M, Kronfeld
I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM
and Brodie C: Protein kinase Calpha and protein kinase Cdelta play
opposite roles in the proliferation and apoptosis of glioma cells.
Cancer Res. 61:4612–4619. 2001.PubMed/NCBI
|
|
9
|
Masur K, Lang K, Niggemann B, Zanker KS
and Entschladen F: High PKC alpha and low E-cadherin expression
contribute to high migratory activity of colon carcinoma cells. Mol
Biol Cell. 12:1973–1982. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanaka Y, Gavrielides MV, Mitsuuchi Y,
Fujii T and Kazanietz MG: Protein kinase C promotes apoptosis in
LNCaP prostate cancer cells through activation of p38 MAPK and
inhibition of the Akt survival pathway. J Biol Chem.
278:33753–33762. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong C, Zhu Y, Liu D, Yu M, Li S, Li Z,
Sun Z and Liu G: Role of protein kinase C-alpha in superficial
bladder carcinoma recurrence. Urology. 65:1228–1232. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chuize K, Yuyan Z, Zhe Z, Tao L, Meng Y
and Qi Y: Protein kinase C-alpha is expressed and activated during
the development of renal cell carcinoma. Urology. 76:514.e1–e5.
2010. View Article : Google Scholar
|
|
13
|
Zhang HT, Zhang D, Zha ZG and Hu CD:
Transcriptional activation of PRMT5 by NF-Y is required for cell
growth and negatively regulated by the PKC/c-Fos signaling in
prostate cancer cells. Biochim Biophys Acta. 1839:1330–1340. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Molè D, Gentilin E, Gagliano T, Tagliati
F, Bondanelli M, Pelizzo MR, Rossi M, Filieri C, Pansini G, Uberti
EC degli and Zatelli MC: Protein kinase C: A putative new target
for the control of human medullary thyroid carcinoma cell
proliferation in vitro. Endocrinology. 153:2088–2098. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bergelin N, Löf C, Balthasar S, Kalhori V
and Törnquist K: S1P1 and VEGFR-2 form a signaling complex with
extracellularly regulated kinase 1/2 and protein kinase C-alpha
regulating ML-1 thyroid carcinoma cell migration. Endocrinology.
151:2994–3005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL,
Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, et al: Definition of PKC-α,
CDK6, and MET as therapeutic targets in triple-negative breast
cancer. Cancer Res. 74:4822–4835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Zhou W, Xue L, Zhang W and Zhan Q:
Nicotine activates YAP1 through nAChRs mediated signaling in
esophageal squamous cell cancer (ESCC). PLoS One. 9:e908362014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langzam L, Koren R, Gal R, Kugel V, Paz A,
Farkas A and Sampson SR: Patterns of protein kinase C isoenzyme
expression in transitional cell carcinoma of bladder. Relation to
degree of malignancy. Am J Clin Pathol. 116:377–385. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Varga A, Czifra G, Tállai B, Németh T,
Kovács I, Kovács L and Bíró T: Tumor grade-dependent alterations in
the protein kinase C isoform pattern in urinary bladder carcinomas.
Eur Urol. 46:462–465. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan J and Byron KL: Ca2+ signalling in rat
vascular smooth muscle cells: A role for protein kinase C at
physiological vasoconstrictor concentrations of vasopressin. J
Physiol. 524:821–831. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bailey TA, Luan H, Tom E, Bielecki TA,
Mohapatra B, Ahmad G, George M, Kelly DL, Natarajan A, Raja SM, et
al: A kinase inhibitor screen reveals protein kinase C-dependent
endocytic recycling of ErbB2 in breast cancer cells. J Biol Chem.
289:30443–30458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aaltonen V, Koivunen J, Laato M and
Peltonen J: PKC inhibitor Go6976 induces mitosis and enhances
doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma
cells. Cancer Lett. 253:97–107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Du HF, Ou LP, Yang X, Song XD, Fan YR, Tan
B, Luo CL and Wu XH: A new PKCα/β/TBX3/E-cadherin pathway is
involved in PLCε-regulated invasion and migration in human bladder
cancer cells. Cell Signal. 26:580–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu S, Jiang Z, Huang Z, Chen X, Qian X,
Gao Q and Zheng H: Migration of retinal pigment epithelium cells is
regulated by protein kinase Cα in vitro. Invest Ophthalmol Vis Sci.
54:7082–7090. 2013. View Article : Google Scholar : PubMed/NCBI
|
